Patent Ductus Arteriosus (PDA) is a congenital cardiovascular anomaly characterized by the persistent patency of the ductus arteriosus, a vital fetal blood vessel that normally closes shortly after birth. This condition leads to abnormal blood flow between the pulmonary artery and the aorta, resulting in the mixing of oxygenated and deoxygenated blood. This can place undue stress on the heart, potentially causing complications such as heart failure if left untreated. Individuals with PDA may exhibit various symptoms, including but not limited to respiratory distress, inadequate weight gain, and an elevated susceptibility to respiratory infections. The clinical presentation can vary, and the severity of symptoms depends on the size of the patent ductus arteriosus. A prompt and accurate diagnosis is essential for effective management. Intervention options range from pharmacological approaches to surgical closure, with the choice depending on factors such as the patient's age, overall health, and the size of the ductus arteriosus. Medications that promote ductal closure or, in more severe cases, surgical procedures to physically seal the ductus arteriosus may be employed.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine